The randomized trial of mixed amino acid medication to prevent post-ERCP pancreatitis
Not Applicable
- Conditions
- post-ERCP pancreatitis
- Registration Number
- JPRN-UMIN000011516
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1) who we could not achieve informed concent, 2) who we evaluated inappropriate for thos trial, 3) who had poor performance status, 4) were under 20 years old, 5) to who ERCP was not completed, 6) who had acute or active pancreatitis, and 7) who had low risk factors of PEP: a) choronic pancreatitis, b) periodical stent exchange, c) ERC to pancreas divisum, and d) the past history of papilla disposal (ex. EST, EPBD and EP).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) new abdominal pain. 2) eleuation in pancreatic enzymes to at least three times the upper limit of the normal range 24 hours after ERCP. 3) extension of hospitalization or medical treatment at least two days.
- Secondary Outcome Measures
Name Time Method adverse event